Monopar Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates

Go back to Monopar Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
(NASDAQ: MNPR) Delayed: 82.65 +13.99 (20.38%)
Previous Close $68.66    52 Week High
Open $68.21    52 Week Low
Day High $83.57    P/E N/A 
Day Low $68.21    EPS
Volume 231,018